Ratliff John D 4
4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed Apr 5, 2018
Insider Transaction Report
Form 4
Ratliff John D
CEO, Covance Drug Development
Transactions
- Award
Restricted Stock Unit
2018-04-03+12,120→ 26,337 total→ Common Stock (12,120 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]The Restricted Stock Units will vest in three installments as follows: 20% of the Restricted Stock Units will vest on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021.
- [F3]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.